Tag: tapering

Together, we can create a new way to support patients tapering psychiatric medications and the medically orphaned will finally feel welcomed.

Past research has framed symptom increases during tapering and discontinuation of psychotropic drugs as a relapse of an underlying “illness.” A new preprint article...

In 2015, the Norwegian Health Minister issued a directive ordering regional health authorities to create a plan for providing mental healthcare without drugs. A...

A new study in Health Expectations led by Trinity College Dublin researchers finds that people withdrawing from psychiatric medications often endure severe symptoms, limited clinical support, and widespread uncertainty about how to taper safely.

Dex Carrington, AKA Jørgen Kjønø, is a Norwegian-American stand-up comedian and actor. He joins us on the Mad In America podcast to talk about his experience with Lyrica and Zyprexa, including a five-and-a-half-year taper after 10 years on the drugs.

I have been on Cymbalta for 17 years now and am gutted that my five-year taper did not free me of the drug.

A new study published in Psychology and Psychotherapy: Theory, Research and Practice finds that psychiatrists and other doctors are the most unhelpful factor for...

For thirty years, Dr. Giovanni Fava has sounded the alarm on the long-term effects of antidepressants and the risks of withdrawal, pushing back against pharmaceutical narratives.

Tapering should be tailored and adjusted to the patient, slowed and more hyperbolic in people who have severe and longstanding reactions.

New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.

A new study shows how different patients respond to tapering antipsychotic medication under expert guidance, highlighting personal empowerment and the complexities of withdrawal.

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

Ayurdhi Dhar interviews Erick Turner about publication bias in antidepressant trials, compromised psychotherapeutic research, and a culture of journal worship.

A new study promotes the use of a standardized approach to antidepressant tapering.

A new literature review reinforces the need to “down-titrate” or taper antidepressants, especially drugs like Celexa and Paxil.

On the MIA Podcast, Dr David Healy discusses World Tapering Day, antidepressant treatment and sensory neuropathy and the difficulties that can be encountered when trying to deprescribe.

A study finds that commonly prescribed antidepressants are associated with the development of diabetes, hypertension, and other diseases.

A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.

New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

Peter Gøtzsche gives advice on what withdrawal symptoms may look like and explains the dangers of—and alternatives to—forced treatment.

Very few doctors know anything about withdrawal and make horrible mistakes. If they taper at all, they do it far too quickly because the few guidelines that exist recommend far too quick tapering.